Abstract:Background and objective: Atrial fibrillation (AF) is a prevalent clinical arrhythmia with a high incidence of disability and mortality. Autonomic nervous system (ANS) plays a crucial role in the onset and persistence of AF, and can lead to electrophysiological changes and alterations in atrial structure. Both animal models and clinical findings suggest that parasympathetic and sympathetic activity within the cardiac ANS could induce atrial remodeling and AF. Remodeling of the cardiac autonomic nerves is a significant structural basis for promoting AF. Given the challenges faced by conventional pharmacological and atrial ablation techniques in the treatment of AF, increasing attention has been paid to autonomic intervention strategies for AF. Current research has demonstrated that the frequency and severity of AF episodes can be significantly reduced by modulating the activity of ANS. ANS neuromodulation is expected to lead more effective and personalized treatment options for patients with AF. The objective of this review is to provide a broader perspective for future related studies by reviewing preclinical and clinical studies of neuromodulation methods for the treatment of AF, searching for relevant approaches to treat AF, as well as identifying the strengths and weaknesses demonstrated by current relevant studies, and providing researchers with a broader overview of the latest neurological treatments for AF. Methods: A narrative review was conducted on the literature on PubMed, WanFang data, and Google Scholar, including all relevant studies published until November 2023. Key content and findings: In this review, we delve into the innervation of cardiac autonomic nerves, the role of the ANS in the development and maintenance of AF, and the current neuromodulation methods for AF treatment. These methods include stellate ganglion (SG) resection or ablation, vagus nerve stimulation (VNS), thoracic subcutaneous nerve stimulation (ScNS), renal denervation (RDN) therapy, ganglionated plexus (GP) ablation, and epicardial botulinum toxin or CaCl2 injection. More and more research suggests that neuromodulation methods for the treatment of AF have broad prospects. Conclusions: ANS plays a crucial role in AF development and maintenance through cardiac autonomic nerve remodeling. Modulating ANS activity can significantly reduce AF frequency and severity, offering more personalized treatment options. Current research on autonomic interventions for AF shows promise for more effective and personalized treatments.

Progress of cardiac autonomic nervous system and atrial fibrillation

Prevention and Reversal of Atrial Fibrillation Inducibility and Autonomic Remodeling by Low-Level Vagosympathetic Nerve Stimulation.

Neuroscientific therapies for atrial fibrillation

Development of neuromodulation for atrial fibrillation: a narrative review

Progress of Autonomic Ganglia Ablation in Atrial Fibrillation

The autonomic nervous system in atrial fibrillation—pathophysiology and non-invasive assessment

Renal Denervation And Pulmonary Vein Isolation In Patients With Drug Resistant Hypertension And Symptomatic Atrial Fibrillation

The Effect of Renin-Angiotensin System Inhibitors on the Recurrence of Atrial Fibrillation after Catheter Ablation

Research on atrial fibrillation mechanisms and prediction of therapeutic prospects: focus on the autonomic nervous system upstream pathways

Autonomic neuronal modulations in cardiac arrhythmias: Current concepts and emerging therapies

The Role of the Autonomic Nervous System as Both "Trigger and "Substrate" in Atrial Fibrillation

Restoring the Autonomic Balance in an Atrial Fibrillation Rat Model by Electroacupuncture at the Neiguan Point

Modulating activity of PVN neurons prevents atrial fibrillation induced circulation dysfunction by electroacupuncture at BL15

Autonomic Function Transformation and Evaluation Following Catheter Ablation in Atrial Fibrillation

Differences of Atrial Electrophysiological Properties between Vagal and Sympathetic Type Atrial Fibrillations

Autonomic modulation before and after paroxysmal atrial fibrillation events in patients with ischemic heart disease

Atrial fibrillation in obstructive sleep apnea: Neural mechanisms and emerging therapies

Advances in Catheter Ablation of Chronic Atrial Fibrillation

Predictors of improvement in left ventricular systolic function after catheter ablation in patients with persistent atrial fibrillation complicated with heart failure

Effect of ablation on sympathetic nerve excitability in patients with atrial fibrillation

Catheter ablation for atrial fibrillation: indications and future perspective